Granules India

Historical price data

Granules India is a vertically integrated pharmaceutical manufacturer with a mission to provide affordable, high-quality medicines globally. A key achievement is its leadership in producing large-volume generic drugs like Paracetamol, Metformin, and Ibuprofen, supported by its own API production, which provides significant cost and supply chain advantages. The company's strategic direction focuses on expanding its portfolio into more complex formulations, growing its presence in regulated markets like the US and Europe, and enhancing its R&D capabilities for value-added generics. Its operational efficiency and scale have made it a critical player in the global pharmaceutical supply chain.

Vertically integrated pharmaceutical manufacturing platform encompassing the production of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs) for generic and over-the-counter drugs.

Granules India competes with large Indian generic firms (Sun Pharma, Dr. Reddy's, Aurobindo) and multinational generics companies (Teva, Viatris). Its primary differentiation is its fully integrated manufacturing model, which provides cost advantages, supply chain control, and resilience against API price fluctuations, allowing it to compete effectively on both price and reliability.